Bright Minds Biosciences Inc (DRUG) — Defensive Interval Ratio

Latest as of December 2025: 116 days

Bright Minds Biosciences Inc (DRUG) has a Defensive Interval Ratio of 116 days as of December 2025. Defensive assets of $502.68K (cash $-, short-term investments $-, receivables $502.68K) cover 116 days of daily cash needs of $4.34K/day. Check Bright Minds Biosciences Inc (DRUG) tangible net worth to evaluate the tangible quality of the company's equity base.

Defensive Interval Ratio

116 days
Days of operational coverage

Defensive Assets

$502.68K
Cash + ST Investments + Receivables

Daily Cash Need

$4.34K
Current Liabilities ÷ 365

Current Liabilities

$1.58 Million
USD

Bright Minds Biosciences Inc Defensive Interval Ratio (2021–2025)

This chart shows how Bright Minds Biosciences Inc's Defensive Interval Ratio has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the ratio stands at 116 days, meaning defensive assets of $502.68K can fund 116 days of operations without new revenue. Also explore Bright Minds Biosciences Inc net asset momentum to track the company's year-over-year net asset growth rate.

Annual Defensive Interval Ratio for Bright Minds Biosciences Inc (2021–2025)

The table below presents the year-by-year Defensive Interval Ratio for Bright Minds Biosciences Inc from 2021 to 2025, covering 5 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see DRUG stock market capitalisation.

Year DIR (days) Defensive Assets (USD) Daily Cash Need Cash ST Investments Change (days)
2025 74 days $475.00K $6.40K/day $- $61.93K ▲ +40 days
2024 35 days $50.22K $1.45K/day $- $- ▼ -125 days
2023 160 days $123.23K $769.47/day $- $86.25K ▲ +100 days
2022 60 days $242.03K $4.03K/day $- $86.25K ▼ -52 days
2021 112 days $196.40K $1.75K/day $- $86.25K
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)